Cite
HARVARD Citation
Abdelnabi, M. et al. (2021). The safety of the use of GP IIB/IIIA inhibitors with different types of dual antiplatelet therapy (DAPT). Atherosclerosis. pp. e265-e266. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abdelnabi, M. et al. (2021). The safety of the use of GP IIB/IIIA inhibitors with different types of dual antiplatelet therapy (DAPT). Atherosclerosis. pp. e265-e266. [Online].